The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Interleukin-6 as a potential biomarker of COVID-19 progression
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,ChinaPreprint
Liu, L., Gao, J.-Y., Hu, W.-M., Zhang, X.-X., Guo, L., Liu, C.-Q., Tang, Y.-W., Lang, C., Mou, F., Yi, Z.-J., et al. (2020) · medRxiv · doi:10.1101/2020.02.20.20025536 · Cited by 103
Wu, C., Hu, X., Song, J., Du, C., Xu, J., Yang, D., Chen, D., Zhong, M., Jiang, J., Xiong, W., et al. (2020) · medRxiv · doi:10.1101/2020.02.26.20028589 · Cited by 82
Yang, P., Ding, Y., Xu, Z., Pu, R., Li, P., Jin, Y., Liu, J., Meng, F., Huang, L., Shi, L., et al. (2020) · medRxiv · doi:10.1101/2020.02.28.20028068 · Cited by 74
Liu, J., Ouyang, L., Guo, P., Wu, H., Fu, P., Chen, Y., Yang, D., Han, X., Cao, Y., Alwalid, O., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.54257 · Cited by 69
Involvement of Interleukin 6 in Hepatitis B Viral Infection
Xia, C., Liu, Y., Chen, Z., & Zheng, M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430386 · Cited by 67
Cited by
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102573 · Cited by 268
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Valizadeh, H., Abdolmohammadi-vahid, S., Danshina, S., Ziya Gencer, M., Ammari, A., Sadeghi, A., Roshangar, L., Aslani, S., Esmaeilzadeh, A., Ghaebi, M., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107088 · Cited by 267
Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A., & Kennedy, R. B. (2020) · Immunological Reviews · doi:10.1111/imr.12897 · Cited by 258
Metadata
- Authors
- Ulhaq, Z. S., & Soraya, G. V.
- Venue
- Médecine et Maladies Infectieuses
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 50
- Issue
- 4
- Pages
- 382-383
- ISSN
- 0399-077X (ISSN-L)
- OpenAlex
- W3014130682
- Cited by
- 331
- References
- 10
- FWCI
- 9.17
- Type
- journal article
- Language
- fr
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin-6 as a potential biomarker of COVID-19 progression. https://app.cochat.ai/papers/10.1016/j.medmal.2020.04.002
- The paper
- Ulhaq, Z. S., & Soraya, G. V. (2020). Interleukin-6 as a potential biomarker of COVID-19 progression. Médecine et Maladies Infectieuses. https://doi.org/10.1016/j.medmal.2020.04.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.